Literature DB >> 7881113

Clinical breast cancer research core.

S M Swain1, S F Honig, E Egan.   

Abstract

The primary purpose of the clinical breast cancer research core is to support the research of the five SPORE projects, and the high priority projects and other studies of SPORE Investigators. The specific aims of the CORE are as follows: The first aim is to provide the project investigators of the SPORE grant with access to a clinical research facility. A second aim is to provide the investigators with a clinical database linked to the tumor bank for the facilitation of studies to improve the diagnosis and prognosis of breast cancer. A third aim is to develop and maintain a serum and DNA lymphocyte bank which will enable investigators to take prognostic or therapy response factors developed in the laboratory and evaluate their clinical significance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7881113     DOI: 10.1007/bf00666169

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  4 in total

Review 1.  Growth control of normal and malignant breast epithelium.

Authors:  M E Lippman; R B Dickson
Journal:  Prog Clin Biol Res       Date:  1990

2.  Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions.

Authors:  K J Cullen; H S Smith; S Hill; N Rosen; M E Lippman
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

Review 3.  Regulation of human breast cancer by secreted growth factors.

Authors:  K J Cullen; D Yee; S E Bates; N Brunner; R Clarke; R E Dickson; K K Huff; S Paik; N Rosen; E Valverius
Journal:  Acta Oncol       Date:  1989       Impact factor: 4.089

4.  Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression.

Authors:  K J Cullen; M E Lippman; D Chow; S Hill; N Rosen; J A Zwiebel
Journal:  Mol Endocrinol       Date:  1992-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.